logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12681024 B1

PDFFull Text
Date of Patent:
Jul. 14, 2026

Filed:

Dec. 20, 2021

Determining interference criticality based on analyte and cell-free hemoglobin concentrations

Applicant:

Radiometer Medical Aps, Brønshøj, DK;

Inventors:

Michael Taagaard, Brønshøj, DK;

Peter Frischauf, Brønshøj, DK;

Assignee:

Radiometer Medical ApS, Brønshøj, DK;

Attorney:

FBT Gibbons LLP

Primary Examiner:

Jennifer Wecker

Assistant Examiner:

Oyeleye Alexander Alabi

Int. Cl.
CPC ...
B01L 3/00 (2006.01); B01D 15/08 (2006.01); B01F 33/302 (2022.01); B01F 33/3033 (2022.01); B01J 8/00 (2006.01); B01J 8/02 (2006.01); B01J 20/285 (2006.01); B01J 20/287 (2006.01); B01J 20/32 (2006.01); B01L 7/00 (2006.01); B01L 9/00 (2006.01); B65G 47/80 (2006.01); B82Y 20/00 (2011.01); B82Y 30/00 (2011.01); B82Y 40/00 (2011.01); C08L 5/08 (2006.01); C12M 1/34 (2006.01); C12M 3/06 (2006.01); C12N 1/14 (2026.01); C12N 1/20 (2026.01); C12Q 1/02 (2006.01); C12Q 1/6806 (2018.01); C12Q 1/6844 (2018.01); C12Q 1/6848 (2018.01); C12Q 1/6851 (2018.01); C12Q 1/686 (2018.01); G01K 1/14 (2021.01); G01N 1/44 (2006.01); G01N 15/10 (2024.01); G01N 15/14 (2024.01); G01N 15/1433 (2024.01); G01N 21/01 (2006.01); G01N 21/03 (2006.01); G01N 21/05 (2006.01); G01N 21/29 (2006.01); G01N 21/33 (2006.01); G01N 21/35 (2014.01); G01N 21/65 (2006.01); G01N 21/75 (2006.01); G01N 21/77 (2006.01); G01N 27/07 (2006.01); G01N 27/28 (2006.01); G01N 27/416 (2006.01); G01N 30/02 (2006.01); G01N 30/60 (2006.01); G01N 30/72 (2006.01); G01N 31/10 (2006.01); G01N 31/12 (2006.01); G01N 33/543 (2006.01); G01N 33/557 (2006.01); G01N 33/564 (2006.01); G01N 33/574 (2006.01); G01N 33/575 (2026.01); G01N 33/57515 (2026.01); G01N 33/58 (2006.01); G01N 33/68 (2006.01); G01N 33/72 (2006.01); G01N 35/00 (2006.01); H05B 45/10 (2020.01);
U.S. Cl.
CPC ...
G01N 33/72 (2013.01);
Abstract

There is presented an apparatus () for automatically measuring an analyte concentration in a liquid sample () comprising the analyte and cell-free hemoglobin and for automatically determining a cell-free hemoglobin interference criticality, said apparatus comprising one or more sensors () for measuring the analyte concentration in the liquid sample, and a cell-free hemoglobin concentration in the liquid sample, and further comprising a data processing device () comprising a processor configured to determine the cell-free hemoglobin interference criticality based on the cell-free hemoglobin concentration, and the analyte concentration, and output a signal () indicative of the cell-free hemoglobin interference criticality at least in case the cell-free hemoglobin interference criticality is within a predetermined range.

Find Patent Forward Citations

Loading…